Phenothiazine molecule provides the basic chemical structure for various classes of pharmacotherapeutic agents
Author
dc.contributor.author
Mosnaim, Aron D.
Author
dc.contributor.author
Ranade, Vasant V.
Author
dc.contributor.author
Wolf, Marion E.
Author
dc.contributor.author
Puente, Javier
Author
dc.contributor.author
Antonieta Valenzuela, M.
Admission date
dc.date.accessioned
2019-03-11T12:51:12Z
Available date
dc.date.available
2019-03-11T12:51:12Z
Publication date
dc.date.issued
2006
Cita de ítem
dc.identifier.citation
American Journal of Therapeutics, Volumen 13, Issue 3, 2018, Pages 261-273
Identifier
dc.identifier.issn
10752765
Identifier
dc.identifier.other
10.1097/01.mjt.0000212897.20458.63
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164166
Abstract
dc.description.abstract
The chemical structure of phenothiazine provides a most valuable molecular template for the development of agents able to interact with a wide variety of biological processes. Synthetic phenothiazines (with aliphatic, methylpiperazine, piperazine-ethanol, piperazine-ethyl, or piperidine side-chain) and/or phenothiazine-derived agents e.g., thioxanthenes, benzepines, imonostilbenes, tricyclic antidepressants, dimetothiazine, and cyproheptadine have been effective in the treatment of a number of medical conditions with widely different etiology. These include various currently clinically used drugs for their significant antihistamic, antipsychotic, anticholinergic (antiparkinson), antipruritic, and/or antiemetic properties. They are also employed, although to a minor extent, as antidepressants, antispasmodics, analgesics, and antiarrhythemics. Some of these agents are also useful as anti-inflammatory, coronary vasodilator, radioprotective, sedative, antitussive, and skeletal muscle-relax